A cohort study including 124 patients with large HCC and 71 patients with small hepatocellular carcinomas found that reduced RFX1 in hepatocellular carcinoma tissues predicted a poor prognosis, as well as a high risk of recurrence [40]. Here, RFX1 is linked to hepatocellular carcinoma.